Bacteremia Caused by <i>Neisseria gonorrhoeae </i>in a Patient Receiving Eculizumab Treatment-Reference-Cited by-同舟云学术

Bacteremia Caused by <i>Neisseria gonorrhoeae </i>in a Patient Receiving Eculizumab Treatment

Published:2021-09-20 Issue:5 Volume:95 Page:367-371
ISSN:0387-5911
Container-title:Kansenshogaku Zasshi
language:en
Short-container-title:J. J. A. Inf. D

Author:

TANIGUCHI Yuka¹,TANAKA Yosuke¹,ANZAI Momoko¹,OHNO Tatsuya¹

Affiliation:

1. Department of Clinical Laboratory, St. Marianna University School of Medicine Yokohama City Seibu Hospital

Publisher

The Japanese Association for Infectious Diseases

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/kansenshogakuzasshi/95/5/95_367/_pdf

Reference12 articles.

1. 1) 日本性感染症学会ガイドライン委員会：第2部疾患別診断と治療．一般社団法人日本性感染症学会編，性感染症診断・治療ガイドライン2020．診断と治療社，東京，2020；p. 53-9.

2. 2) Crew PE, Abara WE, McCulley L, Waldron PE, Kirkcaldy RD, Weston EJ, et al.：Disseminated Gonococcal Infections in Patients Receiving Eculizumab： A Case Series. Clin Infect Dis. 2019；69：596-600.

3. 3) McNamara LA, Topaz N, Wang X, Hariri S, Fox L, MacNeil JR： High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine. MMWR Morb Mortal Wkly Rep. 2017；66：734-7.

4. 4) Saito M, Harada S, Ogasawara R, Izumiyama K, Mori A, Morioka M, et al.：Disseminated Gonococcal Infection Associated with Eculizumab Therapy for Paroxysmal Nocturnal Hemoglobinuria： A Case Report and Literature Review. Int J Gen Med. 2020；13：403-6.

5. 5) Clinical and Laboratory Standards Institute：M100 Performance Standards for Antimicrobial Susceptibility Testing： thirty Informational Supplement 30th. CLSI, Wayne, Pennsylvania, 2020.